3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
45
Lung Neoplasms
29
Neoplasms
26
Colorectal Neoplasms
20
Prostatic Neoplasms
14
Hematologic Neoplasms
10
Uterine Cervical Neoplasms
9
Fatigue
9
Anxiety Disorders
8
Neoplasm Metastasis
7
Lymphoma
7
Hematopoietic and Lymphatic System Neoplasm
7
Papillomavirus Infections
6
Ovarian Neoplasms
5
Multiple Myeloma
5
Melanoma
5
Head and Neck Neoplasms
5
Gastrointestinal Neoplasms
5
Depression
5
Carcinoma, Non-Small-Cell Lung
5
Skin Neoplasms
4
Obesity-Related Malignant Neoplasm
4
Obesity
4
Motor Activity
4
Hematopoietic and Lymphoid System Neoplasm
4
Breast Carcinoma In Situ
4
Urinary Bladder Neoplasms
3
Triple Negative Breast Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pancreatic Neoplasms
3
Interventions
relacorilant
5
Nutrition Assessment
4
Hydrochlorothiazide
3
Amlodipine
3
aliskiren
2
Osilodrostat
2
Lisinopril
2
Bevacizumab
2
Adrenalectomy
2
sacubitril and valsartan sodium hydrate drug combination
1
pembrolizumab
1
pazopanib
1
lutetium Lu 177 dotatate
1
ganirelix
1
gallium Ga 68 dotatate
1
fimasartan
1
enzalutamide
1
clevidipine
1
cediranib
1
bicalutamide
1
benazepril
1
Vitamin D
1
Tumor Necrosis Factors
1
Thiazides
1
Therapeutics
1
Surveys and Questionnaires
1
Sulindac
1
Sodium Chloride
1
Resistance Training
1
Receptors, Androgen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Hypertension
×
Educational Status
×
Clear all
NCT03104543
2024-03-06
CHIIP
Fred Hutchinson Cancer Center
Phase NA
Completed
347 enrolled
10 charts